エベロリムス溶出コバルトクロムステントに対する早期および後期血管反応の多施設比較

基本情報

NCT ID

NCT02014818

ステータス

不明

試験のフェーズ

該当なし

試験タイプ

介入

目標被験者数

104

治験依頼者名

Kobe University

概要

To treat patients with stable coronary artery disease, elective percutaneous coronary intervention (PCI) will be performed with the use of an everolimus-eluting cobalt- chromium stent (everolimus-eluting stent: EES, Xience Prime, Xpedition), which is the current standard drug-eluting stent (DES). Vascular responses at the site of stent placement will be evaluated by optical coherence tomography (OCT) at 1 or 3 months and at 12 months after stent placement, along with observation of changes over time in the target vessel. The relationships between OCT findings and the time course of platelet aggregation and between OCT findings and the occurrence of major cardio- cerebrovascular events will also be elucidated.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)